Ultrasmall silica nanoparticles directly ligate the T cell receptor complex

Abstract

The impact of ultrasmall nanoparticles (<10-nm diameter) on the immune system is poorly understood. Recently, ultrasmall silica nanoparticles (USSN), which have gained increasing attention for therapeutic applications, were shown to stimulate T lymphocytes directly and at relatively low-exposure doses. Delineating underlying mechanisms and associated cell signaling will hasten therapeutic translation and is reported herein. Using competitive binding assays and molecular modeling, we established that the T cell receptor (TCR):CD3 complex is required for USSN-induced T cell activation, and that direct receptor complex–particle interactions are permitted both sterically and electrostatically. Activation is not limited to αβ TCR-bearing T cells since those with γδ TCR showed similar responses, implying that USSN mediate their effect by binding to extracellular domains of the flanking CD3 regions of the TCR complex. We confirmed that USSN initiated the signaling pathway immediately downstream of the TCR with rapid phosphorylation of both ζ-chain–associated protein 70 and linker for activation of T cells protein. However, T cell proliferation or IL-2 secretion were only triggered by USSN when costimulatory anti-CD28 or phorbate esters were present, demonstrating that the specific impact of USSN is in initiation of the primary, nuclear factor of activated T cells-pathway signaling from the TCR complex. Hence, we have established that USSN are partial agonists for the TCR complex because of induction of the primary T cell activation signal. Their ability to bind the TCR complex rapidly, and then to dissolve into benign orthosilicic acid, makes them an appealing option for therapies targeted at transient TCR:CD3 receptor binding.

Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review

“…Elevation in glycolysis is related to an increase in glucose transporter proteins, including GLUT1, which is highly overexpressed in cancer cells [49] In addition, an increase in glycolysis is accompanied by a shunt of central carbon metabolites from the citric acid cycle, including increased expression of pyruvate dehydrogenase kinase 3 (PDK3), which promotes lactate production. A similar phenomenon is called the SAS-NPs moDCs M2 macrophages to M1 phenotype and restored the activity of CD8 + T cells [121] Silica NPs DCs Generating pro-inflammatory cytokines through the P2X7R [118,122] XL-MSNs macrophages Promoting M1 to M2 and inducing pyroptosis [134,135] HA-PEI NPs macrophages Modulating the polarity of macrophages [136,137] TiO2 anatase NPs Macrophages, neutrophils Inducing CD8 + T cell response initiation [140] TiO2, CeO2, and ZnO NPs neutrophil decreasing CD35 but increasing CD66b and CD63 expression [145] siVCAM-1 NPs neutrophil exerting an anti-inflammatory effect [144] SWCNTs neutrophil inhibiting both neutrophil migration and adhesion [146] Nanoparticle-bound NKT NKT activating T cell immune responses [149] USSN T cell receptors promoting T-cell activation, migration, and phenotypic transformation [150] lipid NPs T-cell anti-CD3-conjugated [151] liposomal PHA T-cell mediating T-cell activation [152] LNPs CD4 + cells mediating T-cell activation [155] Warburg effect in cancer cells [50]. Furthermore, pyruvate kinase M2 (PKM2) represents a unique link between aHSCs and cancer cells that promote aerobic glycolysis [51].…”

Nanodrugs Targeting T Cells in Tumor Therapy

“…NP may exert intrinsic T cell stimulatory activity as shown for ultrasmall silica NP (Ø <10 nm) that engaged the T cell receptor and CD3, and thereby induced ζ-chain-associated protein kinase 70 (ZAP70) phosphorylation as well as induction of activation markers (CD25, CD69) ( 20 ). However, T cell proliferation and IL-2 production required the co-application of agonistic CD28 antibody or PMA.…”

Small and dangerous? Potential toxicity mechanisms of common exposure particles and nanoparticles

“…A recent example of this is ultrasmall nanosilica particles, residing within a very specific size range which allows them to bind directly to T Cell receptor (TCR) complexes. The particle binding most likely occurs at the CD3 flanking regions and triggers the 'signal 1' signalling cascade for T cell activation [27,28]. Further examples are likely to emerge for the ligation of additional receptors by ultrasmall nanoparticles.…”